Metabolomics: Technologies and Global Markets

Published - Nov 2015| Analyst - Robert Hunter| Code - BIO055B
Metabolomics: Technologies and Global Markets
Single User License: $2750 Member Price: FREE

Report Highlights

The global metabolomic market totaled $5.9 billion in 2014 and should total $6.8 billion in 2015 and $12.5 billion by 2020, registering a compound annual growth rate (CAGR) of 13.0%.

Report Includes

  • An overview of the commercial potential of the metabolomics research field, the systematic study of the unique chemical fingerprints that cellular processes leaves behind
  • Analyses of global market trends, with data from 2014, estimates for 2015 and projections of compound annual growth rates (CAGRs) through 2020
  • Definitions of metabolome, metabolites, and metabolomics vs. metabonomics
  • Discussion of the conceptual approach in metabolomics: target analysis, metabolite profiling, metabolomics, metabolic fingerprinting
  • Examination of the main structure of the metabolomics market: segments, key application areas, and market participants
  • Separation techniques for metabolomics: gas chromatography, capillary electrophoresis, and high-performance liquid chromatography (HPLC)
  • Patent analysis
  • Company profiles of major players in the field

Report Scope

The scope of the report encompasses the major metabolomic technology types that have been used, as well as the major applications being developed by industry, academic researchers and their commercialization offices, and government agencies. It analyzes current market status, examines future market drivers and presents forecasts of growth over the next five years. Technology developments, including the latest trends, are discussed. Other influential factors such as screening strategies for pharmaceuticals have also been included.

Analyst Credentials

Robert Hunter is a senior management consultant, commercialization consultant and technology and market analyst with over 20 years of experience in life sciences and healthcare. Recent consulting includes market/technology analysis and forecasting of customer adoption and revenue for a high content screening (HCS) technology leader. He is an early investor in a company using stem cells for predictive drug safety testing in vitro. He has a B.S. in Mechanical Engineering from Clemson University and Master of Business Administration from The Tuck School of Business at Dartmouth.

Select reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Feb-2013| Analyst - Marianna Tcherpakov| Code - BIO055A

Report Highlights

The global market for metabolomics was valued at $712 million in 2012 and is expect to reach nearly $1.4 billion in 2017, after increasing at a five-year compound annual growth rate (CAGR) of 14.2%.

Report Includes

  • An overview of the commercial potential of the metabolomics research field, the systematic study of the unique chemical fingerprints that cellular processes leaves behind
  • Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Definitions of metabolome, metabolites, and metabolomics vs. metabonomics
  • Discussion of the conceptual approach in metabolomics: target analysis, metabolite profiling, metabolomics, metabolic fingerprinting
  • Examination of the main structure of the metabolomics market: segments, key application areas, and market participants
  • Separation techniques for metabolomics: gas chromatography, capillary electrophoresis, and high-performance liquid chromatography (HPLC)
  • Patent analysis
  • Comprehensive company profiles of major players
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report